BRIEF published on 10/19/2026 at 10:33, 8 days 6 hours ago Sensorion appoints Peter Weber as Chief Medical Officer Appointment Gene Therapy Hearing Loss Sensory Peter Weber
BRIEF published on 10/19/2026 at 10:33, 8 days 6 hours ago Sensorion nomme Peter Weber au poste de Directeur Médical Nomination Thérapie Génique Sensorion Perte Auditive Peter Weber
PRESS RELEASE published on 10/19/2026 at 10:28, 8 days 7 hours ago Informations privilégiées / Autres communiqués Nomination de Peter Weber, MD, MBA, en tant que Directeur Médical chez Sensorion. Expert en thérapie génique pour surdités génétiques Thérapie Génique Sensorion Directeur Médical Peter Weber Surdité Génétique
BRIEF published on 10/07/2026 at 07:35, 20 days 9 hours ago Louis J. Arcudi III appointed Chief Financial Officer of Sensorion Chief Financial Officer Appointment SENS-601 Sensory Louis J. Arcudi III
BRIEF published on 10/07/2026 at 07:35, 20 days 9 hours ago Louis J. Arcudi III nommé Directeur Financier de Sensorion Nomination Directeur Financier Sensorion SENS-601 Louis J. Arcudi III
PRESS RELEASE published on 10/07/2026 at 07:30, 20 days 9 hours ago Inside Information / Other news releases Sensorion appoints Louis J. Arcudi III as Chief Financial Officer. Arcudi brings extensive biopharmaceutical industry experience to the role Chief Financial Officer Biopharmaceutical Industry Financial Leadership Sensorion Louis J. Arcudi III
PRESS RELEASE published on 10/07/2026 at 07:30, 20 days 9 hours ago Informations privilégiées / Autres communiqués Sensorion annonce la nomination de Louis J. Arcudi III en tant que Directeur Financier, apportant une riche expérience en biopharmaceutique. Il succède à Laurene Danon et travaillera sous la direction de Fred Chereau Biopharmaceutique Directeur Financier Sensorion Fred Chereau Louis J. Arcudi III
BRIEF published on 09/23/2026 at 07:35, 1 month 4 days ago Sensorion Reports 2026 Half-Year Results and Updates Financial Results Gene Therapy Sensorion Hearing Loss SENS-601
BRIEF published on 09/23/2026 at 07:35, 1 month 4 days ago Sensorion publie ses résultats et mises à jour du premier semestre 2026 Résultats Financiers Thérapie Génique Sensorion Perte Auditive SENS-601
PRESS RELEASE published on 09/23/2026 at 07:30, 1 month 4 days ago Informations privilégiées / Communiqué sur comptes, résultats Sensorion publie ses résultats semestriels 2026. Annonce des avancées sur SENS-601, programme de thérapie génique pour la perte auditive. Prévision d'administration au premier patient début 2027 Thérapie Génique Sensorion Perte Auditive SENS-601 Résultats Semestriels 2026
Published on 10/27/2026 at 15:00, 2 hours 28 minutes ago PPX Intercepts High-Grade Gold, Silver, and Copper at Callanquitas, with 13.28 g/t Au, 5,204 g/t Ag and 5.4% Cu Over 1.0 m; and Completes the First Drill Hole at Portachuelos
Published on 10/27/2026 at 14:55, 2 hours 33 minutes ago Sun Valley Minerals Commences Trading on the TSX Venture Exchange; Launches Maiden Drill Program at Tarumán Main
Published on 10/27/2026 at 14:15, 3 hours 13 minutes ago As Ebola Spreads to Multiple Countries, the Importance of NV-387 Oral Gummies Treatment Cannot be Understated - Phase II Clinical Trial Advancing Towards the Second Part, Says NanoViricides
Published on 10/27/2026 at 13:45, 3 hours 43 minutes ago Sekur Private Data Receives US$3.4 Million Per Year Quotation Request from African Government for 1,000 Command Bundle Licenses, 200 SekurOne Accounts and 200 Sekur Tactical Mobile Routers
Published on 10/27/2026 at 13:31, 3 hours 57 minutes ago First Breach Completes First Test Flight of Long Range Strike Drone
Published on 10/27/2026 at 17:15, 13 minutes ago EQS-Adhoc: KAP AG ADJUSTS GUIDANCE FOR THE 2026 FINANCIAL YEAR
Published on 10/27/2026 at 15:49, 1 hour 39 minutes ago EQS-Adhoc: aconnic AG prolongs existing debt financing facility of EUR 23 million
Published on 10/27/2026 at 15:20, 2 hours 8 minutes ago VeriPark achieves the 2026-2027 Microsoft AI Business Solutions Inner Circle award
Published on 10/27/2026 at 15:05, 2 hours 23 minutes ago Ciklum and NiCE Partner to Bring Agentic AI to Enterprise Customer Experiences
Published on 10/27/2026 at 15:00, 2 hours 28 minutes ago BIO-Europe 2026 to Convene Global Biopharma Leaders in Cologne as Dealmaking Confidence Grows
Published on 10/26/2026 at 18:11, 23 hours 17 minutes ago Declaration of transactions on own shares from October 19, 2026 to October 25, 2026
Published on 10/26/2026 at 18:11, 23 hours 17 minutes ago Déclaration des transactions sur actions propres réalisées du 19/10/2026 au 25/10/2026
Published on 10/26/2026 at 17:45, 23 hours 43 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 10/26/2026 at 17:45, 23 hours 43 minutes ago Infotel : Déclaration des transactions sur actions propres réalisées du 19 au 23 octobre 2026 dans le cadre du programme de rachat d’actions.
